In silico-designed mutations increase variable new-antigen receptor single-domain antibodies for VEGF165 neutralization.
Millán-Gómez D, Dueñas S, Muñoz PLA, Camacho-Villegas T, Elosua C, Cabanillas-Bernal O, Escalante T, Perona A, Abia D, Drescher F, Fournier PGJ, Ramos MA, Mares RE, Paniagua-Solis J, Mata-Gonzalez T, Gonzalez-Canudas J, Hoffman RM, Licea-Navarro A, Sánchez-Campos N.
Millán-Gómez D, et al. Among authors: duenas s.
Oncotarget. 2018 Jun 15;9(46):28016-28029. doi: 10.18632/oncotarget.25549. eCollection 2018 Jun 15.
Oncotarget. 2018.
PMID: 29963259
Free PMC article.